Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama
Sponsor: Nanochon, Inc.
Summary
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Official title: A First in Human (FIH) Early Feasibility Study (EFS) to Evaluate the Safety and Performance of the Nanochon Chondrograft™ Implant for Re-surfacing of Cartilage Lesions
Key Details
Gender
All
Age Range
22 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2026-07-30
Completion Date
2027-09
Last Updated
2026-08-21
Healthy Volunteers
No
Conditions
Interventions
Nanochon Chondrograft
Mini arthrotomy or arthroscopic surgical implantation of Nanochon Chondrograft
Locations (1)
The Panama Clinic
Panama City, Provincia de Panamá, Panama